Interview with Terran’s CEO Sam Clark on Terran’s pipeline, including “TerXT” for schizophrenia, a new competitor to ...
In May 2024, we sat down with Sam Clark, CEO of Terran Biosciences, to discuss the exciting developments in their pipeline, particularly their latest schizophrenia therapeutic, TerXT. This new treatment is designed to be a significant competitor to Karuna’ …